New Tools, Old Challenges: What the Future Holds for Malaria Control
The last decade has seen a flood of innovative tools—dual‑ingredient long‑lasting insecticidal nets (LLINs), WHO‑endorsed RTS,S/R21 vaccines, and expanded seasonal malaria chemoprevention (SMC). While these interventions have curtailed millions of cases, the malaria landscape is evolving. Below, I explore the trends that will shape the fight against malaria over the next decade.
1. Dual‑Ingredient Nets Will Become the New Norm
Traditional pyrethroid‑only nets are losing their bite‑proof reputation as resistance spreads across Africa. Dual‑ingredient LLINs, which combine a pyrethroid with a synergist or a second insecticide class, are already proving effective in pilot projects in Kenya and Burkina Faso. WHO’s 2023 guidance predicts that by 2030, at least 70 % of African national malaria programmes will have switched to these nets.
2. Malaria Vaccines Move From Pilot to Routine
Since the first WHO‑prequalified vaccine was approved in 2021, 24 countries have integrated it into their routine immunisation schedules. Looking ahead, the next‑generation R21/Matrix‑M candidate, which demonstrated >80 % efficacy in a Phase III trial, is expected to receive WHO recommendation within the next three years. Scaling this vaccine will hinge on cold‑chain investments and community‑engagement campaigns—areas where lessons from COVID‑19 rollout can be repurposed.
3. Seasonal Malaria Chemoprevention (SMC) Expands Beyond the Sahel
SMC has leapt from 0.2 million children covered in 2012 to over 54 million in 2024, primarily in West Africa. Our own field reports show that integrating SMC with school‑based health services improves adherence and creates synergies with de‑worming programmes. Expect to see SMC pilots in East Africa’s high‑transmission zones by 2026.
4. Drug Resistance Will Drive a New Therapeutic Pipeline
Partial resistance to artemisinin derivatives is now confirmed or suspected in at least eight African nations. The rise of pfhrp2 gene deletions, which compromise rapid diagnostic tests, adds another layer of complexity. In response, several non‑artemisinin combination therapies—such as Ganaplacide‑Lumefantrine—are moving through Phase II trials. The next decade will likely see the first WHO‑prequalified non‑artemisinin regimen, reshaping treatment algorithms worldwide.
Pro tip: Health workers should be trained to recognise treatment failure early and report it through integrated disease surveillance platforms. Early detection can prevent the spread of resistant strains.
5. Urban Mosquitoes Redefine Transmission Hotspots
Anopheles stephensi, an urban‑adapted vector, has colonised nine African nations, thriving in container habitats common to rapidly growing cities. Urban malaria control will require:
- Targeted larviciding in construction sites and drainage systems.
- Community-led source reduction campaigns.
- Smart‑city technologies that map breeding sites in real time.
6. Climate Change and Extreme Weather Will Intensify Outbreaks
Rising temperatures and erratic rainfall expand the geographic window for transmission. Modelling studies from the IPCC suggest that a 1.5 °C warming could increase the suitable habitat for malaria‑carrying mosquitoes by up to 20 % in sub‑Saharan Africa. Early‑warning systems that combine climate data with entomological surveillance will become indispensable.
7. Funding Gaps Threaten Momentum—But Innovation Offers Hope
Global financing plateaued at US$3.9 billion in recent years, far short of the US$9.3 billion target for 2025. Yet, public‑private partnerships are emerging as a lifeline. The “Big Push” initiative, for example, leverages blended finance to unlock additional resources for vaccine rollout and net distribution. Maintaining political commitment—such as the Yaoundé Declaration—remains critical.
Future Outlook: From Control to Elimination
While 282 million cases and 610 000 deaths were reported last year, the trajectory is not set in stone. Success will depend on four interlocking pillars:
- Technology: Wider adoption of next‑gen nets, vaccines, and diagnostics.
- Surveillance: Real‑time data platforms that detect resistance and outbreak hotspots.
- Funding: Sustainable, diversified financing that bridges the current US$5.4 billion shortfall.
- Community Engagement: Culturally tailored communication that builds trust in interventions.
Frequently Asked Questions
- What are dual‑ingredient nets, and why are they important?
- They combine a pyrethroid with a second insecticide or synergist, restoring effectiveness against mosquitoes that have developed pyrethroid resistance.
- How soon will a new malaria vaccine be available?
- The next‑generation R21/Matrix‑M vaccine is expected to receive WHO prequalification within the next three years, pending successful trial outcomes.
- Can malaria be eliminated in high‑transmission zones?
- Elimination is feasible with an integrated strategy that includes vaccines, SMC, high‑coverage nets, robust surveillance, and targeted vector control—especially in urban settings.
- What role does climate change play in malaria spread?
- Warmer temperatures and altered rainfall create new breeding habitats, expanding transmission zones and increasing the frequency of outbreaks.
- How can individuals support malaria control efforts?
- Support reputable NGOs, advocate for sustained funding, and spread awareness about the importance of preventive tools like nets and vaccines.
Stay informed and be part of the solution. Subscribe to our newsletter for the latest updates on malaria research, policy changes, and on‑the‑ground stories from the frontlines.
What are your thoughts on the future of malaria control? Leave a comment below and join the conversation.
Worth a look